---매수대상---/미국 스몰캡 주당 10불 이하
MNPR 8.4
2040FACTORY
2021. 3. 2. 23:38
애널컨센 30
구강점막염
당분간은 마이너스가 커질듯
매출도 없음
현금 18m
오퍼링은 반드시 일어날듯
Monopar Therapeutics Inc.
Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar is building a drug development pipeline through the licens
www.monopartx.com
728x90